GlaxoSmithKline's ViiV Healthcare Wins First FDA OK for Two-Drug HIV Regimen Post author:Sam Post published:November 21, 2017 Post category:BioPharma HIV patients have a new maintenance drug in their arsenal of medication. Source: BioSpace You Might Also Like Valeant to Shave an Additional $200M From Its Mountain of Debt January 25, 2018 Interpace Diagnostics Announces Coverage Of Thyroid Test By August 15, 2017 Ocular Therapeutix to Slash Jobs After FDA Rejection August 1, 2017
